# Bay City Capital: portfolio, investments and team

> Bay City Capital is a vc firm based in United States. 76 investments on record, latest Jul 2017. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/bay-city-capital (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Bay City Capital

Last cheque observed Jul 2017. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

Quiet New fund $1.5M, Feb 2018 VC firm

Seed Series A Series B Life Sciences

Follow Bay City Capital and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fbay-city-capital)

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 76 on record

Since the last cheque **3386** days **00** hrs **00** min **00** sec

Median round **$39M** Rounds led **0 of 76** Sole investor **12 rounds** Exits **20 from the portfolio** Mostly in **United States, 88%**

Pitch Bay City Capital

## Bay City Capital highlights

- 01 76 rounds on record
- 02 Mostly Series A and Series B: 52% of its rounds
- 03 Sole investor in 12 rounds, median $10M
- 04 20 exits from the portfolio

## What they do

> 5 venture capital funds $1.3 billion in capital commitments Invested in over 100 companies worldwide From their own website

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Seed Series A Series B Growth Pre-IPO
- **Sectors:** Life Sciences
- **Based in:** Dallas, United States
- **Cold pitches:** Not accepted

## The record

Every round we can evidence, newest first **76 appearances**

- **2017** 5 rounds
- **Jul** **[Kezar Life Sciences](https://millionrounds.com/company/kezar-life-sciences)** Series B · US · FinSMEs **$50M** With 7 others
- **Jul** **[Menlo Therapeutics](https://millionrounds.com/company/menlo-therapeutics)** Series C · US · FinSMEs **$50M** With 7 others
- **Jun** **[Twist Biosciences](https://millionrounds.com/company/twist-biosciences)** US · FinSMEs **$27M** With 5 others
- **May** **[Iterum Therapeutics](https://millionrounds.com/company/iterum-therapeutics)** Series B · IE · FinSMEs **$65M** With 3 others
- **Jan** **[Oculis](https://millionrounds.com/company/oculis)** CH · Endpts **$20M** With 2 others
- **2016** 1 round
- **Jul** **[Vtesse](https://millionrounds.com/company/vtesse)** Series A · US · FinSMEs **$17M** With 2 others
- **2015** 1 round
- **Apr** **[Merus](https://millionrounds.com/company/merus)** Series C · NL **$79M** With 10 others
- **2014** 6 rounds
- **Dec** **[Interleukin Genetics](https://millionrounds.com/company/interleukin-genetics)** US **$5.0M** With 1 other
- **Sept** **[SynGen](https://millionrounds.com/company/syngen)** Debt · US **$2.0M** Sole investor
- **Aug** **[Civitas Therapeutics](https://millionrounds.com/company/civitas-therapeutics)** Series C · US **$55M** With 11 others
- **Aug** **[Dermira](https://millionrounds.com/company/dermira)** Series C · US **$51M** With 7 others
- **Jan** **[Vtesse](https://millionrounds.com/company/vtesse)** Series A · US **$25M** With 4 others
- **Jan** **[Omicia](https://millionrounds.com/company/omicia)** Series A · US **$6.8M** With 4 others
- **2013** 10 rounds
- **Oct** **[PharmAkea Therapeutics](https://millionrounds.com/company/pharmakea-therapeutics)** Series A · US · finsmes.com **$10M** Sole investor
- **Oct** **[Merus](https://millionrounds.com/company/merus)** Series B · NL · finsmes.com **$40M** With 4 others
- **Oct** **[Cydan](https://millionrounds.com/company/cydan)** Venture · US · finsmes.com **$10M** With 3 others
- **Sept** **[Civitas Therapeutics](https://millionrounds.com/company/civitas-therapeutics)** Series B · US · finsmes.com **$38M** With 6 others
- **Jul** **[TRIA Beauty](https://millionrounds.com/company/tria-beauty)** Growth · US · pevc.dowjones.com **$46M** With 6 others
- **Jun** **[Dermira](https://millionrounds.com/company/dermira)** Series B · US · businesswire.com **$35M** With 3 others
- **May** **[Interleukin Genetics](https://millionrounds.com/company/interleukin-genetics)** Growth · US · bizjournals.com **$12M** Sole investor
- **Mar** **[Nabsys](https://millionrounds.com/company/nabsys)** Series D · US · sec.gov **$35M** With 2 others
- **Mar** **[Nevro](https://millionrounds.com/company/nevro)** Series C · US · finsmes.com **$48M** With 8 others
- **Feb** **[Aviir](https://millionrounds.com/company/aviir)** Series B · US · finsmes.com **$10M** With 3 others
- **2012** 3 rounds
- **Nov** **[Ascendancy](https://millionrounds.com/company/ascendancy)** US **Undisclosed** Sole investor
- **Apr** **[SynGen](https://millionrounds.com/company/syngen)** Series A · US · bizjournals.com **$5.0M** Sole investor
- **Feb** **[Altheos](https://millionrounds.com/company/altheos)** Series A · US · fiercebiotech.com **$13M** With 2 others
- **2011** 6 rounds
- **Dec** **[Aviir](https://millionrounds.com/company/aviir)** Series B · US · pehub.com **$10M** With 3 others
- **Oct** **[Dermira](https://millionrounds.com/company/dermira)** Series A · US · finsmes.com **$42M** With 2 others
- **Jul** **[Nevro](https://millionrounds.com/company/nevro)** Venture · US · finsmes.com **$58M** With 6 others
- **Jun** **[Aviir](https://millionrounds.com/company/aviir)** Venture · US · sec.gov **$3.0M** With 2 others
- **Feb** **[Conatus Pharmaceuticals](https://millionrounds.com/company/conatus-pharmaceuticals)** Series B · US · pharmalive.com **$20M** With 5 others
- **Jan** **[NextWave Pharmaceuticals](https://millionrounds.com/company/nextwave-pharmaceuticals)** Series C · US · finsmes.com **$45M** With 7 others
- **2010** 6 rounds
- **Nov** **[Accriva Diagnostics](https://millionrounds.com/company/accriva-diagnostics)** Series A · US **Undisclosed** Sole investor
- **Oct** **[IDEV Technologies](https://millionrounds.com/company/idev-technologies)** Series D · US · finsmes.com **$46M** With 4 others
- **Apr** **[Altheos](https://millionrounds.com/company/altheos)** Series A · US · fiercebiotech.com **$20M** With 4 others
- **Mar** **[Ion Torrent](https://millionrounds.com/company/ion-torrent)** Series C · US **$37M** Sole investor
- **Jan** **[Merus](https://millionrounds.com/company/merus)** Series B · NL · merus.nl **$30M** With 3 others
- **Jan** **[Aviir](https://millionrounds.com/company/aviir)** Venture · US · deals.venturebeat.com **$4.2M** With 2 others
- **2009** 8 rounds
- **Nov** **[CymaBay Therapeutics](https://millionrounds.com/company/cymabay-therapeutics)** Venture · US · metabolex.com **$8.6M** With 11 others
- **Nov** **[Calypso Medical](https://millionrounds.com/company/calypso-medical)** Series E · US · onbiovc.com **$50M** With 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **1 named**

CG **Carl Goldfischer, MD** Managing Director of the Managing Member i Filing they signed

We also hold **9** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What they claim to have backed

From their own portfolio page (on their website)

**0** of 1 we have independently watched raise

Browsehappy

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

## Exits from the portfolio

Companies it backed that were later bought or listed **20 in all**

**[Hyperion Therapeutics](https://millionrounds.com/company/hyperion-therapeutics)** Bought by Horizon Pharma **$1.1B** Mar 2015

**[Civitas Therapeutics](https://millionrounds.com/company/civitas-therapeutics)** Bought by Acorda Therapeutics **$525M** Sept 2014

**[Aciex Therapeutics](https://millionrounds.com/company/aciex-therapeutics)** Bought by NicOx **$120M** Jul 2014

**[Cadence Pharmaceuticals](https://millionrounds.com/company/cadence-pharmaceuticals)** Bought by [Mallinckrodt](https://millionrounds.com/fund/mallinckrodt) **$1.3B** Feb 2014

**[NuPathe](https://millionrounds.com/company/nupathe)** Bought by Endo Health Solutions **$105M** Dec 2013

**[IDEV Technologies](https://millionrounds.com/company/idev-technologies)** Bought by [Abbott Labs](https://millionrounds.com/fund/abbott-labs) **$310M** Jul 2013

**[PTC Therapeutics](https://millionrounds.com/company/ptc-therapeutics)** Listed **$125M** Jun 2013

**[Conatus Pharmaceuticals](https://millionrounds.com/company/conatus-pharmaceuticals)** Listed **$69M** Jun 2013

**[Epizyme](https://millionrounds.com/company/epizyme)** Listed **$60M** May 2013

**[MAP Pharmaceuticals](https://millionrounds.com/company/map-pharmaceuticals)** Bought by [Allergan](https://millionrounds.com/fund/allergan) **$958M** Jan 2013

**[Epocrates](https://millionrounds.com/company/epocrates)** Bought by Athenahealth **Undisclosed** Jan 2013

**[NextWave Pharmaceuticals](https://millionrounds.com/company/nextwave-pharmaceuticals)** Bought by [Pfizer](https://millionrounds.com/fund/pfizer) **Undisclosed** Oct 2012

**[Aragon Surgical](https://millionrounds.com/company/aragon-surgical)** Bought by Aesculap **Undisclosed** Sept 2011

**[Calypso Medical](https://millionrounds.com/company/calypso-medical)** Bought by Varian Medical Systems **Undisclosed** Sept 2011

**[Epocrates](https://millionrounds.com/company/epocrates)** Listed **Undisclosed** Feb 2011

**[Ion Torrent](https://millionrounds.com/company/ion-torrent)** Bought by [Life Technologies](https://millionrounds.com/fund/life-technologies) **$725M** Aug 2010

**[NuPathe](https://millionrounds.com/company/nupathe)** Listed **Undisclosed** Aug 2010

**[Reliant Pharmaceuticals](https://millionrounds.com/company/reliant-pharmaceuticals)** Bought by [GlaxoSmithKline](https://millionrounds.com/fund/glaxosmithkline) **$1.6B** Nov 2007

**[Pharmion](https://millionrounds.com/company/pharmion)** Bought by [Celgene](https://millionrounds.com/fund/celgene) **$2.9B** Nov 2007

**[Syrrx](https://millionrounds.com/company/syrrx)** Bought by [Takeda Pharmaceutical](https://millionrounds.com/fund/takeda-pharmaceutical) **$270M** Feb 2005

An exit counts when it came after the firm's first round in the company. From historical deal records.

New fund on file

**$1.5M**

raised in Feb 2018

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Seed Series A Series B

Median round joined **$39M** the round, not its cheque Alone, median **$10M**

Led 0 of 76 rounds **0%**

- **Sole investor:** 12 rounds
- **Last cheque:** Jul 2017
- **Exits:** 20 from the portfolio

Rounds by stage said on their site

- Series A said *17*
- Series B said *16*
- Venture *14*
- Series C *11*
- Series D *5*
- Seed said *-*
- Growth said *-*

Cheques by year Led Joined

2000 2017

Often in the room with

- [Aberdare Ventures](https://millionrounds.com/fund/aberdare-ventures) 13
- [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 10
- [New Leaf Venture Partners](https://millionrounds.com/fund/new-leaf-venture-partners) 8
- [Novo Holdings A/S](https://millionrounds.com/fund/novo-holdings-a-s) 8
- [Canaan](https://millionrounds.com/fund/canaan-partners) 7
- [Alta Partners](https://millionrounds.com/fund/alta-partners) 6

**Pitching Bay City Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Bay City Capital. A count of rooms they were both in, not a relationship either has claimed.

[**Aberdare Ventures** VC firm **13** rounds together](https://millionrounds.com/fund/aberdare-ventures)[**New Enterprise Associates** VC firm **10** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**New Leaf Venture Partners** VC firm **8** rounds together](https://millionrounds.com/fund/new-leaf-venture-partners)[**Novo Holdings A/S** Growth equity **8** rounds together](https://millionrounds.com/fund/novo-holdings-a-s)[**Canaan** VC firm **7** rounds together](https://millionrounds.com/fund/canaan-partners)[**Alta Partners** VC firm **6** rounds together](https://millionrounds.com/fund/alta-partners)[**Delphi Ventures** VC firm **6** rounds together](https://millionrounds.com/fund/delphi-ventures)[**MPM Capital** Private equity **6** rounds together](https://millionrounds.com/fund/mpm-bioimpact)[**Sofinnova Investments** VC firm **6** rounds together](https://millionrounds.com/fund/sofinnova-investments)[**Versant Ventures** VC firm **6** rounds together](https://millionrounds.com/fund/versant-ventures)[**Birchmere Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/birchmere-ventures)[**Novartis Venture Fund** Corporate VC **5** rounds together](https://millionrounds.com/fund/novartis-venture-fund)

## Recently backed

The latest companies Bay City Capital put money into.

[**Kezar Life Sciences** $50M · Jul 2017](https://millionrounds.com/company/kezar-life-sciences)[**Iterum Therapeutics** $65M · May 2017](https://millionrounds.com/company/iterum-therapeutics)

## Quick answers about Bay City Capital

### What does Bay City Capital invest in?

Bay City Capital invests most often at Series A and Series B (52% of the rounds on record), in sectors such as Life Sciences.

### How active is Bay City Capital?

76 investments on record, 0 of them in the last 12 months. The most recent was in Jul 2017.

### What has Bay City Capital invested in recently?

Its most recent investments on record: Kezar Life Sciences (Series B, Jul 2017), Menlo Therapeutics (Series C, Jul 2017) and Twist Biosciences (Undisclosed round, Jun 2017).

### How big are Bay City Capital's cheques?

The median round it joins is $39M.

### Does Bay City Capital lead rounds?

Rarely, if at all: none of its 76 investments on record names it as the lead.

### Where does Bay City Capital invest?

Most of the companies it backs are in the United States (88%) and the Netherlands (8%).

### Is Bay City Capital investing now?

No investments in the last 12 months; the latest was in Jul 2017.

### Who does Bay City Capital invest alongside?

Most often Aberdare Ventures (13 rounds together), New Enterprise Associates (10 rounds together) and New Leaf Venture Partners (8 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=bay-city-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=bay-city-capital)